What’s the state of play of COVID-19… – European Commission | Facebook

European Commission, profile picture

What's the state of play of COVID-19 vaccines in the EU? A snapshot of where vaccines are in the authorisation process 👇

🔷 𝗧𝘄𝗼 𝘃𝗮𝗰𝗰𝗶𝗻𝗲𝘀 𝗮𝗿𝗲 𝘂𝗻𝗱𝗲𝗿 𝗿𝗼𝗹𝗹𝗶𝗻𝗴 𝗿𝗲𝘃𝗶𝗲𝘄. The rolling review process will help speed up the timetable for evaluation and authorisation.

🔷 𝗔 𝗽𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹 𝗳𝗼𝘂𝗿𝘁𝗵 𝘃𝗮𝗰𝗰𝗶𝗻𝗲 𝗶𝘀 𝘂𝗻𝗱𝗲𝗿 𝗲𝘃𝗮𝗹𝘂𝗮𝘁𝗶𝗼𝗻. The European Medicines Agency (EMA) has received the application for conditional marketing authorisation for the vaccine produced by Janssen. EMA is evaluating its safety and effectiveness under an accelerated timetable. If authorised, this would be the fourth COVID-19 vaccine available in the EU.

🔷 𝗠𝗼𝗿𝗲 𝗱𝗼𝘀𝗲𝘀 𝗼𝗳 𝗮𝘂𝘁𝗵𝗼𝗿𝗶𝘀𝗲𝗱 𝘃𝗮𝗰𝗰𝗶𝗻𝗲𝘀. This week we secured an additional 300 million doses of the Moderna vaccine, which is one of three vaccines already authorised and in use throughout the EU.


May be an image of text that says 'COVID-19 vaccines in the EU BIONTECH/PFIZER MODERNA ASTRAZENECA JANSSEN Authorised and in distribution CUREVAC NOVAVAX Submitted application to EMA Under rolling review European Commission'

Source: https://m.facebook.com/story.php?story_fbid=3833885439992241&id=107898832590939&__tn__=-R


Publication author

offline 3 years

Laeticia Linden

Comments: 0Publics: 306Registration: 10-04-2018